Azenta, Inc. (AZTA) shareholders
Close on Nov 17, 2026Market cap $2.01BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Quentin Koffey Joint filing with Politan Capital Management LP (9.40%), Politan Capital Management GP LLC (9.40%) and 1 more | 4,611,752 | 9.40% | 13D (active) amendment | Nov 1, 2024 |
| Vanguard Portfolio Management | 2,466,192 | 5.35% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AZTA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7,529,450 | 17.19% | $192.15M | +804,461 | 0.00% |
| Politan Capital Management LP | 4,622,450 | 10.55% | $117.96M | – | 46.26% |
| Vanguard Portfolio Management LLC | 2,493,844 | 5.69% | $63.64M | +43,352 | 0.00% |
| Vanguard Capital Management LLC | 1,870,174 | 4.27% | $47.73M | +41,883 | 0.00% |
| State Street Corp | 1,859,945 | 4.25% | $47.47M | +97,522 | 0.00% |
| Massachusetts Financial Services Co /Ma/ | 1,423,818 | 3.25% | $36.34M | −364,432 | 0.01% |
| D. E. Shaw & Co., Inc. | 1,341,164 | 3.06% | $34.23M | +662,009 | 0.02% |
| Morgan Stanley | 1,330,194 | 3.04% | $33.95M | +464,585 | 0.00% |
| Front Street Capital Management, Inc. | 1,301,398 | 2.97% | $33.21M | +412,389 | 3.77% |
| Dimensional Fund Advisors LP | 1,232,473 | 2.81% | $31.45M | −827,849 | 0.01% |
| Allspring Global Investments Holdings, LLC | 1,192,008 | 2.72% | $31.22M | −421,906 | 0.05% |
| Neuberger Berman Group LLC | 1,131,616 | 2.58% | $28.88M | +228,221 | 0.02% |
| Geode Capital Management, LLC | 1,100,849 | 2.51% | $28.10M | +91,272 | 0.00% |
| American Capital Management Inc | 1,061,490 | 2.42% | $27.09M | −234,534 | 1.21% |
| GW&K Investment Management, LLC | 988,429 | 2.26% | $25.23M | +15,173 | 0.20% |
| Royce & Associates LP | 891,419 | 2.03% | $22.75M | +368,111 | 0.18% |
| Snyder Capital Management L P | 872,544 | 1.99% | $22.27M | +839,350 | 0.38% |
| Victory Capital Management Inc | 854,005 | 1.95% | $21.79M | +17,298 | 0.01% |
| Ameriprise Financial Inc | 768,049 | 1.75% | $19.60M | +508,798 | 0.00% |
| Bank Of America Corp /De/ | 668,398 | 1.53% | $17.06M | +200,352 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 249 | 50M | 100.0% | 45 / 94 | 80 / 52 | 9M | 12M |
| Q1 2026 | 260 | 53M | 100.0% | 45 / 91 | 94 / 74 | 14M | 9M |
| Q4 2025 | 294 | 52M | 100.0% | 52 / 94 | 105 / 31 | 7M | 5M |
| Q3 2025 | 277 | 51M | 100.0% | 42 / 73 | 110 / 42 | 4M | 7M |
| Q2 2025 | 278 | 54M | 100.0% | 53 / 104 | 92 / 66 | 10M | 9M |
| Q1 2025 | 294 | 53M | 100.0% | 44 / 104 | 110 / 57 | 5M | 4M |
| Q4 2024 | 311 | 52M | 100.0% | 53 / 93 | 126 / 53 | 8M | 6M |
| Q3 2024 | 314 | 50M | 100.0% | 45 / 91 | 133 / 49 | 8M | 8M |
| Q2 2024 | 322 | 55M | 100.0% | 38 / 94 | 134 / 40 | 2M | 6M |
| Q1 2024 | 328 | 59M | 100.0% | 46 / 101 | 130 / 36 | 3M | 4M |
| Q4 2023 | 319 | 60M | 100.0% | 47 / 84 | 145 / 32 | 4M | 5M |
| Q3 2023 | 309 | 61M | 100.0% | 41 / 73 | 145 / 37 | 7M | 12M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
273 funds held AZTA in Q2 2026, 50% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of AZTA | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 2,472,054 | 5.64% | $63.09M | 0.06% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,321,722 | 3.02% | $33.73M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,098,311 | 2.51% | $28.03M | 0.03% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 950,375 | 2.17% | $24.25M | 0.01% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 602,659 | 1.38% | $15.38M | 0.02% | Jun 30, 2026 |
| MFS New Discovery Fund | 556,939 | 1.27% | $12.74M | 0.60% | May 31, 2026 |
| Allspring Special Small Cap Value Fund | 519,641 | 1.19% | $13.26M | 0.45% | Jun 30, 2026 |
| MFS New Discovery Value Fund | 503,524 | 1.15% | $11.52M | 0.46% | May 31, 2026 |
| Columbia Small Cap Value Discovery Fund | 486,224 | 1.11% | $13.68M | 0.55% | Jul 31, 2026 |
| Tarkio Fund | 479,825 | 1.10% | $10.98M | 4.26% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 470,527 | 1.07% | $12.01M | 0.01% | Jun 30, 2026 |
| Bridge Builder Small/Mid Cap Value Fund | 463,029 | 1.06% | $11.82M | 0.11% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 460,024 | 1.05% | $12.94M | 0.04% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 394,415 | 0.90% | $10.07M | 0.07% | Jun 30, 2026 |
| U.S. Small Cap Value Portfolio | 380,552 | 0.87% | $10.70M | 0.06% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John Marotta | President and CEO, Director | 213,194 | 0.49% | Dec 3, 2025 |
| Erik J. Bello | VP Chief Accounting Officer | 10,401 | 0.02% | Nov 16, 2026 |
| Lawrence Y. Lin | EVP, CFO and Treasurer | 129,048 | 0.29% | Nov 16, 2026 |
| Ephraim Starr | SVP, Gen Counsel & Secretary | 105,711 | 0.24% | Nov 16, 2026 |
| Olga Pirogova | SVP and CHRO | 63,895 | 0.15% | Nov 16, 2026 |
| William E. Martin Iii | President Multiomics | 50,638 | 0.12% | Nov 16, 2026 |
| Martin D. Madaus | Interim CEO | 41,308 | 0.09% | Oct 23, 2026 |
| Ginger Zhou | SVP and GM, Multiomics | 38,755 | 0.09% | Nov 25, 2025 |
| Violetta Hughes | VP, Chief Accounting Officer | 9,603 | 0.02% | Feb 4, 2025 |
| David Dong Wang | SVP & GM, SMS | 23,974 | 0.05% | Dec 5, 2024 |
| Herman Cueto | EVP, Chief Financial Officer | 23,892 | 0.05% | Nov 21, 2024 |
| Jason Joseph | SVP, General Counsel, Secy. | 112,564 | 0.26% | Nov 21, 2024 |
| William L. Cornog | Director | 45,498 | 0.10% | May 19, 2026 |
| Quentin Koffey | Director | 4,622,450 | 10.55% | May 12, 2026 |
| Erica McLaughlin | Director | 22,521 | 0.05% | Feb 6, 2026 |
| Frank Casal | Director | 21,803 | 0.05% | Feb 6, 2026 |
| Robyn C. Davis | Director | 33,627 | 0.08% | Feb 6, 2026 |
| Tina Susan Nova | Director | 15,772 | 0.04% | Feb 6, 2026 |
| Dipal Doshi | Director | 9,703 | 0.02% | Feb 6, 2026 |
| Alan J. Malus | Director | 17,035 | 0.04% | Nov 14, 2025 |
| Didier Hirsch | Director | 3,465 | 0.01% | Nov 19, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Olga Pirogova SVP and CHRO | Nov 16, 2026 | Tax withholding | −5,009 | $43.86 | $219.69K | 63,895 |
| Olga Pirogova SVP and CHRO | Nov 16, 2026 | Tax withholding | −2,072 | $43.86 | $90.88K | 68,904 |
| Olga Pirogova SVP and CHRO | Nov 16, 2026 | Award | +13,412 | – | – | 70,976 |
| Lawrence Y. Lin EVP, CFO and Treasurer | Nov 16, 2026 | Tax withholding | −4,413 | $43.86 | $193.55K | 129,048 |
| Olga Pirogova SVP and CHRO | Nov 12, 2026 | Award | +10,339 | – | – | 57,564 |
| Lawrence Y. Lin EVP, CFO and Treasurer | Nov 12, 2026 | Award | +23,262 | – | – | 133,461 |
| Ephraim Starr SVP, Gen Counsel & Secretary | Nov 12, 2026 | Award | +21,711 | – | – | 105,711 |
| William E. Martin Iii President Multiomics | Nov 12, 2026 | Award | +17,576 | – | – | 50,638 |
| Erik J. Bello VP Chief Accounting Officer | Nov 12, 2026 | Award | +5,815 | – | – | 10,401 |
| Martin D. Madaus Interim CEO | Oct 22, 2026 | Tax withholding | −1,294 | $36.01 | $46.60K | 41,308 |
| Martin D. Madaus Interim CEO | Sep 22, 2026 | Tax withholding | −1,456 | $34.28 | $49.91K | 42,602 |
| Erik J. Bello VP Chief Accounting Officer | Sep 15, 2026 | Award | +4,586 | – | – | 4,586 |
| Martin D. Madaus Interim CEO | Sep 14, 2026 | Award | +36,653 | – | – | 44,058 |
| William E. Martin Iii President Multiomics | Sep 14, 2026 | Award | +15,272 | – | – | 33,062 |
| Olga Pirogova SVP and CHRO | Sep 14, 2026 | Award | +15,272 | – | – | 47,225 |
| Ephraim Starr SVP, Gen Counsel & Secretary | Sep 14, 2026 | Award | +15,272 | – | – | 84,000 |
| Lawrence Y. Lin EVP, CFO and Treasurer | Sep 14, 2026 | Award | +30,544 | – | – | 110,199 |
| Olga Pirogova SVP and CHRO | Aug 9, 2026 | Tax withholding | −1,085 | $32.04 | $34.76K | 31,953 |
| Ephraim Starr SVP, Gen Counsel & Secretary | Jul 31, 2026 | Buy | +335 | $24.17 | $8.10K | 68,728 |
| William L. Cornog Director | May 18, 2026 | Buy | +10,000 | $16.38 | $163.80K | 19,703 |
| Ephraim Starr SVP, Gen Counsel & Secretary | May 15, 2026 | Tax withholding | −3,621 | $16.02 | $58.01K | 68,393 |
| William E. Martin Iii President Multiomics | Apr 28, 2026 | Award | +17,790 | $24.24 | $431.23K | 17,790 |
| Tina Susan Nova Director | Feb 6, 2026 | Award | +5,663 | $27.85 | $157.71K | 15,772 |
| Quentin Koffey Director | Feb 5, 2026 | Award | +5,663 | – | – | 10,698 |
| Frank Casal Director | Feb 5, 2026 | Award | +7,243 | $27.85 | $201.72K | 21,803 |
| Erica McLaughlin Director | Feb 5, 2026 | Award | +5,663 | $27.85 | $157.71K | 22,521 |
| Dipal Doshi Director | Feb 5, 2026 | Award | +5,663 | $27.85 | $157.71K | 9,703 |
| John Marotta President and CEO, Director | Nov 24, 2025 | Award | +118,194 | – | – | 213,194 |
| Lawrence Y. Lin EVP, CFO and Treasurer | Nov 24, 2025 | Award | +36,681 | – | – | 79,655 |
| Olga Pirogova SVP and CHRO | Nov 24, 2025 | Award | +16,303 | – | – | 33,038 |
| John Marotta President and CEO, Director | Nov 24, 2025 | Award | +122,269 | – | – | 217,269 |
| Ephraim Starr SVP, Gen Counsel & Secretary | Nov 24, 2025 | Award | +34,235 | – | – | 72,014 |
| Ginger Zhou SVP and GM, Multiomics | Nov 24, 2025 | Award | +13,042 | – | – | 38,755 |
| John Marotta President and CEO, Director | Nov 14, 2025 | Tax withholding | −10,980 | $29.75 | $326.66K | 95,000 |
| Ginger Zhou SVP and GM, Multiomics | Nov 14, 2025 | Tax withholding | −1,118 | $29.75 | $33.26K | 25,713 |
| Lawrence Y. Lin EVP, CFO and Treasurer | Nov 14, 2025 | Tax withholding | −3,039 | $29.75 | $90.41K | 42,974 |
| Olga Pirogova SVP and CHRO | Nov 14, 2025 | Tax withholding | −1,553 | $29.75 | $46.20K | 16,735 |
| John Marotta President and CEO, Director | Sep 10, 2025 | Sale | −316 | $29.41 | $9.29K | 105,980 |
| Olga Pirogova SVP and CHRO | Aug 12, 2025 | Sale | −1,085 | $28.54 | $30.97K | 18,288 |
| Ginger Zhou SVP and GM, Multiomics | Aug 12, 2025 | Sale | −1,085 | $28.54 | $30.97K | 26,831 |
| Olga Pirogova SVP and CHRO | Aug 12, 2025 | Returned to company | −1,085 | $28.54 | $30.97K | 18,288 |
| Ginger Zhou SVP and GM, Multiomics | Aug 12, 2025 | Returned to company | −1,085 | $28.54 | $30.97K | 26,831 |
| Lawrence Y. Lin EVP, CFO and Treasurer | Aug 11, 2025 | Buy | +2,500 | $27.96 | $69.90K | 46,013 |
| John Marotta President and CEO, Director | Jun 2, 2025 | Buy | +1,000 | $25.99 | $25.99K | 107,296 |
| John Marotta President and CEO, Director | Jun 2, 2025 | Award | +1,000 | $25.99 | $25.99K | 107,296 |
| Alan J. Malus Director | May 30, 2025 | Buy | +12,000 | $26.65 | $319.80K | 17,035 |
| Alan J. Malus Director | May 30, 2025 | Award | +12,000 | $26.65 | $319.80K | 17,035 |
| William L. Cornog Director | May 20, 2025 | Buy | +2,748 | $27.37 | $75.21K | 25,795 |
| William L. Cornog Director | May 20, 2025 | Award | +2,748 | $27.37 | $75.21K | 21,755 |
| William L. Cornog Director | May 19, 2025 | Buy | +4,152 | $26.98 | $112.02K | 23,047 |
| William L. Cornog Director | May 19, 2025 | Award | +4,152 | $26.98 | $112.02K | 19,007 |
| William L. Cornog Director | May 16, 2025 | Buy | +100 | $26.50 | $2.65K | 18,895 |
| William L. Cornog Director | May 16, 2025 | Award | +100 | $26.50 | $2.65K | 14,855 |
| Ephraim Starr SVP, Gen Counsel & Secretary | May 15, 2025 | Award | +37,779 | $26.71 | $1.01M | 37,779 |
| John Marotta President and CEO, Director | May 9, 2025 | Award | +1,796.17 | $27.49 | $49.38K | 106,296 |
| Lawrence Y. Lin EVP, CFO and Treasurer | May 9, 2025 | Award | +4,000 | $27.49 | $109.96K | 43,513 |
| John Marotta President and CEO, Director | May 9, 2025 | Award | +1,796.17 | $27.84 | $50.01K | 106,296 |
| John Marotta President and CEO, Director | May 8, 2025 | Award | +3,637.64 | $27.49 | $100.00K | 104,500 |
| Lawrence Y. Lin EVP, CFO and Treasurer | May 8, 2025 | Award | +2,000 | $27.67 | $55.34K | 39,513 |
| John Marotta President and CEO, Director | May 8, 2025 | Award | +3,637.64 | $27.49 | $100.00K | 102,658 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Azenta's stock actually held short. Settlement fails (shares not delivered on time) peaked at 116,708 shares on Oct 7, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Jason Joseph Officer | Aug 1, 2024 | 1,000 | $62.05K | Aug 1, 2024 | Restricted Stock |
| Jason Joseph Officer | Jul 25, 2024 | 3,000 | $180.00K | Jul 25, 2024 | Performance Shares |
| Violetta Hughes Officer | May 20, 2024 | 584 | $29.99K | May 20, 2024 | RESTRICTED STOCK |
| Jason Joseph Officer | Apr 1, 2024 | 1,000 | $60.15K | Apr 1, 2024 | Performance Shares |
| Jason Joseph Officer | Mar 8, 2024 | 4,000 | $270.00K | Mar 8, 2024 | Restricted Stock |
| Jason Joseph Officer | Mar 7, 2024 | 9,000 | $586.00K | Mar 7, 2024 | Performance Shares |
| Puhy Dorothy E Former Director | Feb 14, 2024 | 3,604 | $237.86K | Feb 14, 2024 | Equity Incentive Plan |
| Joseph R. Martin Revocable Trust dtd. 01/16/2024 Former Chairman; Trustee of Joseph R Martin Rev Tr | Feb 8, 2024 | 5,175 | $350.45K | Feb 8, 2024 | stock grant |
| Robin Vacha Officer | Dec 5, 2023 | 5,175 | $292.91K | Dec 5, 2023 | PERFORMANCE SHARES |
| David C. Gray Officer | Nov 17, 2023 | 5,179 | $254.60K | Nov 17, 2023 | PERFORMANCE SHARES |
| David C. Gray Officer | Aug 11, 2023 | 10,877 | $609.43K | Aug 11, 2023 | PERFORMANCE SHARES |
| Robin Vacha Officer | Aug 10, 2023 | 7,400 | $407.01K | Aug 10, 2023 | PERFORMANCE SHARES |
| David C. Gray Officer | Aug 10, 2023 | 10,732 | $604.40K | Aug 10, 2023 | PERFORMANCE SHARES |
| Zane Ellen M Director | Aug 9, 2023 | 18,766 | $1.05M | Aug 9, 2023 | Award |
| Joseph R. Martin Chairman of the Board | Jun 5, 2023 | 2,400 | $103.99K | Jun 5, 2023 | STOCK GRANT |
Congress trades
15 trades in Azenta reported by 3 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Gilbert Cisneros CA31 | Bought | Mar 3, 2026 | $1K–15K | Apr 7, 2026 |
| Gilbert Cisneros CA31 | Bought | Jan 15, 2026 | $1K–15K | Feb 13, 2026 |
| Gilbert Cisneros CA31 | Bought | Oct 9, 2025 | $1K–15K | Nov 18, 2025 |
| Josh Gottheimer NJ05 · joint account | Sold | Mar 19, 2025 | $1K–15K | Apr 10, 2025 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Sep 15, 2023 | $1K–15K | Oct 15, 2023 |
| Josh Gottheimer NJ05 · joint account | Bought | Jul 14, 2023 | $1K–15K | Aug 21, 2023 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Jun 13, 2023 | $1K–15K | Jul 11, 2023 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Dec 15, 2021 | $1K–15K | Jan 10, 2022 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Dec 3, 2021 | $1K–15K | Jan 10, 2022 |
| Susie Lee NV03 · joint account | Sold | May 21, 2021 | $1K–15K | Jun 14, 2021 |
| Susie Lee NV03 · joint account | Bought | Feb 23, 2021 | $1K–15K | Mar 11, 2021 |
| Susie Lee NV03 · joint account | Bought | Feb 9, 2021 | $1K–15K | Mar 11, 2021 |
| Josh Gottheimer NJ05 · joint account | Bought | Jan 5, 2021 | $1K–15K | Feb 9, 2021 |
| Gilbert Cisneros CA31 | Bought | Dec 7, 2020 | $1K–15K | Jan 11, 2021 |
| Josh Gottheimer NJ05 · joint account | Bought | Dec 2, 2020 | $1K–15K | Jan 7, 2021 |
See a number that looks wrong?